Skip to main content
. Author manuscript; available in PMC: 2022 Mar 29.
Published in final edited form as: J Surg Oncol. 2021 Oct 27;125(3):475–483. doi: 10.1002/jso.26734

FIGURE 3.

FIGURE 3

(A) Five-year overall survival for patients with lymphovascular invasion undergoing RR versus TAX_A. (B). Five-year overall survival for patients with positive resection margins undergoing RR versus TAX_A. (C) Five-year overall survival for patients with poorly differentiated or undifferentiated tumors undergoing RR versus TAX_A. RR, radical resection; TAX_A, transanal excision without adjuvant therapy